1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Standard NIH omnibus dates Jan 5, Apr 5, Sep 5; topic active Sep 2026-Sep 2028
NIH Organ-on-Chip Diabetes SBIR: Microphysiological Systems for Diabetes, Kidney, and Urologic Complications Research is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). This highlighted topic encourages collaborative research applying human microphysiological systems (MPSs), or organ-on-chip platforms, to cell and tissue types relevant to diabetes and its kidney and urologic complications.
High-priority areas include systems with at least two diabetes-relevant human tissues, validation of diabetes pathophysiology, studies of crosstalk between tissues, and models with mature cell types and interacting compartments.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: US for-profit small businesses, 500 or fewer employees, majority US-owned. Confirm the full requirements in the official notice before applying.
The current listing shows up to $323,090 Phase I; up to $2,153,927 Phase II. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for NIH Organ-on-Chip Diabetes SBIR: Microphysiological Systems for Diabetes, Kidney, and Urologic Complications Research are due January 5, 2027. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
NIH Organ-on-Chip Diabetes SBIR: Microphysiological Systems for Diabetes, Kidney, and Urologic Complications Research is funded by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
NIDDK Small Business Programs (SBIR/STTR) is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The NIDDK participates in SBIR and STTR programs to support innovative research conducted by small businesses with the potential for commercialization. While their primary focus areas are digestive diseases, nutritional disorders, and obesity, innovations in medical devices that could have an impact on related circulatory or chronic conditions might be considered.
NIDDK Exploratory/Developmental Research Grant Program in Sickle Cell Disease (R21) is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). This opportunity supports mission-aligned projects and measurable outcomes related to sickle cell disease research. The R21 mechanism encourages the development of new research activities in categorical program areas.